240 related articles for article (PubMed ID: 37164246)
1. Screening study of anti-emetics to improve GDF15-induced malaise and anorexia: Implications for emesis control.
Borner T; Doebley SA; Furst CD; Pataro AM; Halas JG; Gao X; Choi GK; Ramadan SA; Chow A; De Jonghe BC
Physiol Behav; 2023 Aug; 267():114229. PubMed ID: 37164246
[TBL] [Abstract][Full Text] [Related]
2. GDF15 Induces Anorexia through Nausea and Emesis.
Borner T; Shaulson ED; Ghidewon MY; Barnett AB; Horn CC; Doyle RP; Grill HJ; Hayes MR; De Jonghe BC
Cell Metab; 2020 Feb; 31(2):351-362.e5. PubMed ID: 31928886
[TBL] [Abstract][Full Text] [Related]
3. [The development of a new QOL Questionnaire on chemotherapy - induced emesis and vomiting--investigation of reliability and validity. Group for Investigation of QOL Questionnaire for Anti-Emetics Used in Cancer Chemotherapy. Joint Research Group for Tropisetron Double-Blind Comparative study].
Ishihara Y; Nukariya N; Kobayashi K; Yoneda S; Matsuda T; Yakushiji M; Yamakido M; Fukuoka M; Niitani H; Furue H
Gan To Kagaku Ryoho; 1996 May; 23(6):745-55. PubMed ID: 8645026
[TBL] [Abstract][Full Text] [Related]
4. GDF15 Induces an Aversive Visceral Malaise State that Drives Anorexia and Weight Loss.
Borner T; Wald HS; Ghidewon MY; Zhang B; Wu Z; De Jonghe BC; Breen D; Grill HJ
Cell Rep; 2020 Apr; 31(3):107543. PubMed ID: 32320650
[TBL] [Abstract][Full Text] [Related]
5. Growth differentiation factor 15 (GDF15) and semaglutide inhibit food intake and body weight through largely distinct, additive mechanisms.
Ghidewon M; Wald HS; McKnight AD; De Jonghe BC; Breen DM; Alhadeff AL; Borner T; Grill HJ
Diabetes Obes Metab; 2022 Jun; 24(6):1010-1020. PubMed ID: 35129264
[TBL] [Abstract][Full Text] [Related]
6. Anti-emetic therapy in cancer chemotherapy: current status.
Herrstedt J; Dombernowsky P
Basic Clin Pharmacol Toxicol; 2007 Sep; 101(3):143-50. PubMed ID: 17697032
[TBL] [Abstract][Full Text] [Related]
7. Creation of a Peptide Antagonist of the GFRAL-RET Receptor Complex for the Treatment of GDF15-Induced Malaise.
Borner T; Tinsley IC; Milliken BT; Doebley SA; Najjar NR; Kerwood DJ; De Jonghe BC; Hayes MR; Doyle RP
J Med Chem; 2023 Aug; 66(16):11237-11249. PubMed ID: 37506293
[TBL] [Abstract][Full Text] [Related]
8. [Clinical effects of granisetron and methylpredonisolone against delayed emesis and anorexia induced by anticancer agents].
Kawashima T; Wada T; Morita N; Okamoto K; Matsuhira J; Sakamoto T
Gan To Kagaku Ryoho; 1994 Dec; 21(16):2849-51. PubMed ID: 7993127
[No Abstract] [Full Text] [Related]
9. Mechanisms and management of chemotherapy-induced nausea and vomiting.
Allan SG
Blood Rev; 1987 Mar; 1(1):50-7. PubMed ID: 3332087
[TBL] [Abstract][Full Text] [Related]
10. [Nausea and vomiting].
Fujii M
Nihon Rinsho; 2003 Jun; 61(6):954-8. PubMed ID: 12806942
[TBL] [Abstract][Full Text] [Related]
11. Hepatic IRE1α-XBP1 signaling promotes GDF15-mediated anorexia and body weight loss in chemotherapy.
Tang Y; Yao T; Tian X; Xia X; Huang X; Qin Z; Shen Z; Zhao L; Zhao Y; Diao B; Ping Y; Zheng X; Xu Y; Chen H; Qian T; Ma T; Zhou B; Xu S; Zhou Q; Liu Y; Shao M; Chen W; Shan B; Wu Y
J Exp Med; 2024 Jul; 221(7):. PubMed ID: 38695876
[TBL] [Abstract][Full Text] [Related]
12. The management of chemotherapy-induced nausea and vomiting.
Gralla RJ; Tyson LB; Kris MG; Clark RA
Med Clin North Am; 1987 Mar; 71(2):289-301. PubMed ID: 3546981
[TBL] [Abstract][Full Text] [Related]
13. Reduction of chemotherapy-induced anorexia, nausea, and emesis through a structured nursing intervention: a cluster-randomized multicenter trial.
Jahn P; Renz P; Stukenkemper J; Book K; Kuss O; Jordan K; Horn I; Thoke-Colberg A; Schmoll HJ; Landenberger M
Support Care Cancer; 2009 Dec; 17(12):1543-52. PubMed ID: 19629539
[TBL] [Abstract][Full Text] [Related]
14. Olanzapine Administration Reduces Chemotherapy-Induced Nausea Behavior in Rats.
Jaime-Lara RB; Borner T; Holland RA; Shaulson E; Brooks B; De Jonghe BC
Biol Res Nurs; 2021 Oct; 23(4):584-595. PubMed ID: 33789505
[TBL] [Abstract][Full Text] [Related]
15. LPS induces rapid increase in GDF15 levels in mice, rats, and humans but is not required for anorexia in mice.
Patel AR; Frikke-Schmidt H; Bezy O; Sabatini PV; Rittig N; Jessen N; Myers MG; Seeley RJ
Am J Physiol Gastrointest Liver Physiol; 2022 Feb; 322(2):G247-G255. PubMed ID: 34935522
[TBL] [Abstract][Full Text] [Related]
16. Progress in reducing nausea and emesis. Comparisons of ondansetron (Zofran), granisetron (Kytril), and tropisetron (Navoban).
Morrow GR; Hickok JT; Rosenthal SN
Cancer; 1995 Aug; 76(3):343-57. PubMed ID: 8625113
[TBL] [Abstract][Full Text] [Related]
17. GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates.
Breen DM; Kim H; Bennett D; Calle RA; Collins S; Esquejo RM; He T; Joaquim S; Joyce A; Lambert M; Lin L; Pettersen B; Qiao S; Rossulek M; Weber G; Wu Z; Zhang BB; Birnbaum MJ
Cell Metab; 2020 Dec; 32(6):938-950.e6. PubMed ID: 33207247
[TBL] [Abstract][Full Text] [Related]
18. Antiemetics for cancer chemotherapy-induced nausea and vomiting. A review of agents in development.
Rizk AN; Hesketh PJ
Drugs R D; 1999 Oct; 2(4):229-35. PubMed ID: 10659396
[TBL] [Abstract][Full Text] [Related]
19. Additive effect of rikkunshito, an herbal medicine, on chemotherapy-induced nausea, vomiting, and anorexia in uterine cervical or corpus cancer patients treated with cisplatin and paclitaxel: results of a randomized phase II study (JORTC KMP-02).
Ohnishi S; Watari H; Kanno M; Ohba Y; Takeuchi S; Miyaji T; Oyamada S; Nomura E; Kato H; Sugiyama T; Asaka M; Sakuragi N; Yamaguchi T; Uezono Y; Iwase S
J Gynecol Oncol; 2017 Sep; 28(5):e44. PubMed ID: 28657216
[TBL] [Abstract][Full Text] [Related]
20. Options in the treatment of chemotherapy-induced emesis.
Pendergrass KB
Cancer Pract; 1998; 6(5):276-81. PubMed ID: 9767346
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
